Navigation Links
Hologic Announces Third Quarter Fiscal 2008 Operating Results
Date:7/30/2008

cal 2007 by eliminating certain of the more significant effects of the acquisitions that took place since fiscal 2006. Management uses these non- GAAP financial measures for this purpose, and these amounts are also excluded by the Company when calculating compliance with the Company's financial covenants under its credit facility. When analyzing the Company's operating performance, investors should not consider these non-GAAP measures as a substitute for net income and EPS prepared in accordance with GAAP.

Non-GAAP Financial Guidance:

This press release also includes estimates of future non-GAAP adjusted earnings and earnings per share. A reconciliation of these amounts to expected GAAP results is not practical at this time as GAAP expenses associated with our acquisition of Third Wave, which we expect to be significant, such as the write-off of in process research and development, the amortization of intangible assets and costs associated with the write-up of inventory cannot be determined until we complete our valuation of the assets we recently acquired from Third Wave.

Contact: Deborah R. Gordon Frances Doria

Vice President, Investor Relations Director, Investor Relations

Hologic, Inc. Hologic, Inc.

(781) 999-7716 (781) 999-7377


'/>"/>
SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Psychological downside to strike action
2. Psychological and Social Issues Associated With Tooth Loss
3. Psychological and social issues associated with tooth loss
4. Hologic, Inc. Announces Grant of Early Termination of Antitrust Waiting Period for Third Wave Technologies, Inc. Tender Offer
5. Hologic to Present at the Jefferies 2nd Annual Healthcare Conference
6. Hologic to Acquire Third Wave Technologies
7. Metformin increases pathologic complete response rates in breast cancer patients with diabetes
8. Hologic to Present at NASDAQs 21st Investor Program in London
9. Hologic Announces Organizational Change
10. Can pathological techniques help identify primary colorectal signet ring cell carcinoma?
11. Electric shocks can cause neurologic and neuropsychological symptoms

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...panic health advocates committed to achieving mean...N, Nov. 7 "Tonight the ...rd the voice of America,s families by passing the ...nate must deliver, without delay, on the promise o... Delgado, President and CEO of the National Allian...
(Date:11/8/2009)...ealth Care Reform Bill ,, Critical legislatio...all Americans ,, CHICAGO, Nov. 7 /PRNewswire-U...presentatives passed by a vote of 220-215, critica...then Medicare for seniors and end discrimination b...icans out of affordable health coverage. ,, T...
(Date:11/7/2009)...e-USNewswire/ -- Speaker Nancy Pelosi spoke on th...ffordable Health Care for America Act. The House ... are the Speaker,s remarks. ,, "Madam Speaker,...our nation and for American families. For nearly ...ilosophy -- as far back as Teddy Roosevelt -- have...
(Date:11/7/2009)...wswire/ -- Members of the AMA are trying a last-mi...escinding the AMA,s support of HR 3962. ,, "We...le to their PATIENTS, not the leadership of the AM...e Association of American Physicians and Surgeons,...cal groups. ,, "If the AMA leadership ignores ...
(Date:11/7/2009)...or Life Action endorses a key vote today on the Ho...lkemper-Lipinski-Smith Amendment, an Amendment tha...in health care reform. ,, Americans United for Lif...aid, "Americans United for Life Action strongly su...r-Lipinski-Smith Amendment to prohibit abortion ma...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2
...LC, today announced the,U.S. Food and Drug Adminis...late(TM) devices for use in intervertebral fusion ...solid bone grafts and morselized,bone, without the...erPlate is designed to,facilitate rapid fusion and...
...e, REDMOND, Wash., Sept. 21 EndoGastric Solution...ming Transoral Incisionless,Fundoplication (TIF(TM...sease has received FDA clearance. Patients have al... anesthesia,transoral, incisionless, without any e...
... A new study by researchers at the University of S...od for you. , Researchers found that a storyline...with teen obesity, hypertension and healthy eating...alth Communication and now available online, offer...
...tent symptoms can give warning, experts say , SATU... the "silent killer," may not always be so silent,...ar pelvic exams and pay attention to possible symp...he disease. , September is Ovarian Cancer Awarenes...
...orked hard to get into,summer shape, but now a sea...games may have taken a toll on our waistlines. Now...ck into the one thing that will never lie to,us. ...aphics and,photos for free and unrestricted use at...
...ng is a,statement by Robert Greenstein, executive ...ties, on the new congressional SCHIP agreement:, ... several million,low-income uninsured children, a ...ured, not middle-income children with,private cove...
Other Medicine News:Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 2Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 3Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 4Health News:ER episode impacts viewers' health knowledge and behavior 2Health News:Pelvic Exams Can Help Spot Ovarian Cancer 2Health News:Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement 2
(Date:11/6/2009)... MURRYSVILLE, Pa., Nov. 6 Philips ...r Disease Control and Prevention (CDC) to raise aw...chronic sleep insufficiency. The CDC,s release of ...y-state differences in sleeplessness is a mileston.... ,, As a long-time educator, industry leader ...
(Date:11/6/2009)... NEW YORK, Nov. 6 Keryx ...d a conference call on Tuesday, November 10, 2009 ... financial results and business outlook for the re...icer of the Company, will host the call. Keryx wi...in a press release to be issued prior to the call....
(Date:11/6/2009)... ATLANTA, Nov. 6 GeoVax...or "the Company"), an Atlanta-based, biopharmaceut...s caused by HIV-1 (Human Immunodeficiency Virus) a...ird quarter 2009 financial results and provided an...President and Chief Executive Officer commented, "...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Discovery May Pave Way to Better Diabetes Care 56967 1Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference 14004 1Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference 14004 2Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 1Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 2Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 3Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 4Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 5
...bled Time to Progression and Overall Response Rate...bine + Placebo in Patients with 2nd or 3rd Line Me... Biopharmaceuticals, Inc. (Nasdaq: KERX ) today ...1 (perifosine), the Company,s Akt-inhibitor for ca...ent for advanced colon cancer. Abstract #4081, en...
...SCO Meeting , , INDIANAPOLIS, May 30 Semafore Ph...discovery and development company, today presented...r targeted pan-PI3K/mTORC1/2 inhibitor, SF1126, at...SCO) Annual Meeting, being held in Orlando, Florid...a University Simon Cancer Center in Indianapolis,...
Other Medicine Technology:Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 2Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 3Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 4Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 5Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 6Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients 2Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients 3
... peels are often thought of as very aggressive and...l™ TCA peels are very different from the sta...h many ingredients including lactic acid, ascorbic...c and azelaic acids to produce dramatic results wi...
...ating rapid exfoliator. Lactic Acid is is recommen... agents in skin care products, as well as those th...nd want to improve results. ,Lactic Acid is a natu...h the chemical free style of Peel RX Medi Peel pro...
Specialist's Skin Peel Kit
Glycolic Peels (Medical)
Medicine Products: